Objective: to evaluate efficacy, safety and tolerability of ketogenic diet in patients with treatment resistant GBM

Inclusion criteria

  • Age 18-65
  • Astrocytoma grade 4 (glioblastoma multiforme)
  • GBM recurrence or progression after surgical resection/debulking, radiation and temozolamide
  • Karnovsky Performance Score


Mid-Atlantic Epilepsy & Sleep Center
Pavel Klein, M.D.

Ivana Tyrlikova, Arkady Barber, Lenka Goldman, study coordinators
Phone: 301 530 9744
Fax: 301 530 0046